|
US3423507A
(en)
|
1966-02-25 |
1969-01-21 |
Schering Corp |
Method of treating benign prostratic hypertrophy
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4329364A
(en)
|
1974-09-11 |
1982-05-11 |
Schering Corporation |
Antiandrogenic agents and methods for the treatment of androgen dependent disease states
|
|
US4263428A
(en)
|
1978-03-24 |
1981-04-21 |
The Regents Of The University Of California |
Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
|
|
DE2817157A1
(de)
|
1978-04-17 |
1979-10-25 |
Schering Ag |
Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie
|
|
FR2465486A1
(fr)
|
1979-09-21 |
1981-03-27 |
Roussel Uclaf |
Nouvelle application utilisant la lh-rh ou des agonistes
|
|
IE52535B1
(en)
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
|
DE3121153A1
(de)
|
1981-05-22 |
1982-12-09 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
"verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie"
|
|
US4457489A
(en)
|
1981-07-13 |
1984-07-03 |
Gilmore Samuel E |
Subsea fluid conduit connections for remote controlled valves
|
|
EP0088046B1
(de)
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
|
HUT35524A
(en)
|
1983-08-02 |
1985-07-29 |
Hoechst Ag |
Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance
|
|
EP0143949B1
(en)
|
1983-11-01 |
1988-10-12 |
TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION |
Pharmaceutical composition containing urokinase
|
|
US4659695A
(en)
|
1985-02-08 |
1987-04-21 |
Fernand Labrie |
Method of treatment of prostate cancer
|
|
US4775660A
(en)
|
1984-08-02 |
1988-10-04 |
Fernand Labrie |
Treatment of breast cancer by combination therapy
|
|
US4760053A
(en)
|
1984-08-02 |
1988-07-26 |
Fernand Labrie |
Combination therapy for selected sex steroid dependent cancers
|
|
CA1310924C
(en)
|
1986-04-24 |
1992-12-01 |
Francis P. Mccormick |
Infective drug delivery system
|
|
US4970154A
(en)
|
1987-10-09 |
1990-11-13 |
Baylor College Of Medicine |
Method for inserting foreign genes into cells using pulsed radiofrequency
|
|
US4892538A
(en)
|
1987-11-17 |
1990-01-09 |
Brown University Research Foundation |
In vivo delivery of neurotransmitters by implanted, encapsulated cells
|
|
US5106627A
(en)
|
1987-11-17 |
1992-04-21 |
Brown University Research Foundation |
Neurological therapy devices
|
|
US5158881A
(en)
|
1987-11-17 |
1992-10-27 |
Brown University Research Foundation |
Method and system for encapsulating cells in a tubular extrudate in separate cell compartments
|
|
US5672344A
(en)
|
1987-12-30 |
1997-09-30 |
The Regents Of The University Of Michigan |
Viral-mediated gene transfer system
|
|
US5011472A
(en)
|
1988-09-06 |
1991-04-30 |
Brown University Research Foundation |
Implantable delivery system for biological factors
|
|
US5948634A
(en)
|
1988-12-21 |
1999-09-07 |
The General Hospital Coporation |
Neural thread protein gene expression and detection of alzheimer's disease
|
|
EP0378924B1
(en)
|
1988-12-21 |
1996-11-13 |
The General Hospital Corporation |
Detection of neurological disease or dysfunction
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5676954A
(en)
|
1989-11-03 |
1997-10-14 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
|
JPH06256387A
(ja)
|
1991-06-14 |
1994-09-13 |
Suetsuna Yoko |
新規なペプチド、その製法およびそれを有効成分とする 血圧降下剤
|
|
KR100392244B1
(ko)
|
1993-04-20 |
2003-11-28 |
더 제너럴 호스피탈 코포레이션 |
신경사단백질유전자발현및알쯔하이머병의검출
|
|
ES2178654T3
(es)
|
1993-08-12 |
2003-01-01 |
Neurotech Sa |
Capsulas biocompatibles inmonoaisladoras que contienen celulas geneticamente alteradas para el suministro de moleculas biologicamente activas.
|
|
US5631236A
(en)
|
1993-08-26 |
1997-05-20 |
Baylor College Of Medicine |
Gene therapy for solid tumors, using a DNA sequence encoding HSV-Tk or VZV-Tk
|
|
MX9504664A
(es)
|
1994-03-07 |
1997-05-31 |
Dow Chemical Co |
Conjugados de dendrimeros bioactivos y/o dirigidos.
|
|
US5484720A
(en)
|
1994-09-08 |
1996-01-16 |
Genentech, Inc. |
Methods for calcium phosphate transfection
|
|
JPH11506722A
(ja)
|
1995-06-07 |
1999-06-15 |
ベイラー・カレッジ・オブ・メディスン |
細胞に核酸を送達するための核酸運搬体
|
|
BR9711795A
(pt)
|
1996-03-26 |
2000-06-06 |
Razvant T Radulescu |
Peptìdeos tendo propriedades antiproliferativas
|
|
US5679559A
(en)
|
1996-07-03 |
1997-10-21 |
University Of Utah Research Foundation |
Cationic polymer and lipoprotein-containing system for gene delivery
|
|
AU749348B2
(en)
|
1997-02-26 |
2002-06-27 |
General Hospital Corporation, The |
Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
|
|
AU9655698A
(en)
|
1997-10-10 |
1999-05-03 |
Astra Aktiebolag |
Synthetic genes with immunomodulatory effects
|
|
EP1135468B1
(en)
|
1998-11-10 |
2010-01-06 |
University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
|
EP1135494A2
(en)
|
1998-12-11 |
2001-09-26 |
Incyte Pharmaceuticals, Inc. |
Neuron-associated proteins
|
|
AU3517000A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
50 human secreted proteins
|
|
JP2002543764A
(ja)
|
1999-03-19 |
2002-12-24 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
46個のヒト分泌タンパク質
|
|
JP2002539842A
(ja)
|
1999-03-26 |
2002-11-26 |
ヒューマン ジノーム サイエンシーズ, インコーポレイテッド |
45個のヒト分泌タンパク質
|
|
EP1171462A2
(en)
|
1999-03-26 |
2002-01-16 |
Human Genome Sciences, Inc. |
49 human secreted proteins
|
|
EP1220947A2
(en)
|
1999-03-26 |
2002-07-10 |
Human Genome Sciences, Inc. |
50 human secreted proteins
|
|
CN1300779A
(zh)
|
1999-12-22 |
2001-06-27 |
上海博德基因开发有限公司 |
一种新的多肽-人神经元线蛋白17和编码这种多肽的多核苷酸
|
|
WO2002000718A2
(en)
|
2000-06-26 |
2002-01-03 |
Millennium Pharmaceuticals, Inc. |
A human calcium channel protein and uses thereof
|
|
US7259232B1
(en)
|
2000-10-27 |
2007-08-21 |
Nymox Pharmaceutical Corporation |
Preferred segments of neural thread protein
|
|
CA2325666A1
(fr)
|
2000-12-01 |
2002-06-01 |
Institut Pasteur |
Peptides immunogeniques mutes derives de r9m, polynucleotides les codants et leurs usages therapeutiques
|
|
US6783969B1
(en)
|
2001-03-05 |
2004-08-31 |
Nuvelo, Inc. |
Cathepsin V-like polypeptides
|
|
DE60222745T2
(de)
|
2001-03-08 |
2008-07-10 |
Nymox Pharmaceutical Corp., St. Laurent |
Verwendung von neurofilamentproteinen zur behandlung von tumoren
|
|
JP2004529179A
(ja)
|
2001-05-16 |
2004-09-24 |
ナイモックス コーポレーション |
神経線維タンパク質のセグメントを使用する細胞死の予防法
|
|
BR0209990A
(pt)
|
2001-05-25 |
2004-06-29 |
Nymox Corp |
Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
|
|
DE60217507T2
(de)
|
2001-07-19 |
2007-11-15 |
Nymox Corp., Saint-Laurent |
Peptide für die behandlung von tumoren und anderen zuständen, die das entfernen oder zerstören von zellen erfordern
|
|
US7317077B2
(en)
|
2001-11-16 |
2008-01-08 |
Nymox Pharmaceutical Corporation |
Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
|
|
WO2005113720A2
(en)
|
2004-05-19 |
2005-12-01 |
Auburn University |
A strategy for designing patient-specific anti-cancer drugs
|
|
PL1994152T3
(pl)
*
|
2006-02-28 |
2013-05-31 |
Nymox Corp |
Peptydy skuteczne w leczeniu nowotworów i innych stanów wymagających usunięcia lub zniszczenia komórek
|
|
EA200801942A1
(ru)
|
2006-03-10 |
2009-02-27 |
Наймокс Корпорейшн |
Способ предотвращения или уменьшения риска возникновения рака с использованием пептидов на основе белков нервных волокон
|
|
US9243035B2
(en)
|
2013-11-26 |
2016-01-26 |
Nymox Corporation |
Peptides effective in the treatment of conditions requiring the removal or destruction of cells
|
|
US20160215031A1
(en)
|
2015-01-27 |
2016-07-28 |
Nymox Pharnaceutical Corporation |
Method of treating disorders requiring destruction or removal of cells
|
|
US20160361380A1
(en)
|
2015-06-12 |
2016-12-15 |
Nymox Corporation |
Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations
|
|
US11628202B2
(en)
|
2015-07-24 |
2023-04-18 |
Nymox Corporation |
Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
|
|
US10172910B2
(en)
*
|
2016-07-28 |
2019-01-08 |
Nymox Corporation |
Method of preventing or reducing the incidence of acute urinary retention
|